Detailansicht

Wissensnetz

Person

Christoph Schliemann (1977-)

Arzt

Name	Christoph Schliemann
Zeit	1977- (Lebensdaten)
Ort	Bonn (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Weitere Angaben	Diss. Fachbereich Medizin
Quelle	AM Metadaten
Datensatztyp	Person
GND-Nummer	129938548
Datensatz-ID	129938548
Beteiligt an alle anzeigen Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients Multiparametric MRI for characterization of the tumour microenvironment Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study Central airway obstruction treatment with self-expanding covered Y-carina nitinol stents: A single center retrospective analysis Die Bedeutung von cfDNA im 24h-Urin beim Multiplen Myelom Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer Prognostische Bedeutung von Kollagen Typ VI beim Multiplen Myelom Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer The role of small nucleolar Ribonucleoprotein complexes in lung cancer Überleben und prognostische Faktoren von Patienten mit akuter myeloischer Leukämie auf der internistischen Intensivstation des Universitätsklinikums Münster A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases Expression der Angiopoietine und ihres Rezeptors Tie-2 im Knochenmark von Patienten mit akuter myeloischer Leukämie Expression der Angiopoietine und ihres Rezeptors Tie-2 im Knochenmark von Patienten mit akuter myeloischer Leukämie

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Christoph Schliemann (1977-)

Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients

Multiparametric MRI for characterization of the tumour microenvironment

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears

Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

Central airway obstruction treatment with self-expanding covered Y-carina nitinol stents: A single center retrospective analysis

Die Bedeutung von cfDNA im 24h-Urin beim Multiplen Myelom

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario

Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma

Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer

Prognostische Bedeutung von Kollagen Typ VI beim Multiplen Myelom

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer

The role of small nucleolar Ribonucleoprotein complexes in lung cancer

Überleben und prognostische Faktoren von Patienten mit akuter myeloischer Leukämie auf der internistischen Intensivstation des Universitätsklinikums Münster

A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia

Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases

Expression der Angiopoietine und ihres Rezeptors Tie-2 im Knochenmark von Patienten mit akuter myeloischer Leukämie

Expression der Angiopoietine und ihres Rezeptors Tie-2 im Knochenmark von Patienten mit akuter myeloischer Leukämie